Company Overview

Patheon, part of Thermo Fisher Scientific, delivers integrated end-to-end CDMO services designed to reduce drug development timelines and simplify global supply chains.

Capabilities encompass early-phase formulation screening, high-potency API synthesis (HPAPI), viral vector manufacturing, sterile injectable fill-finish, and commercial packaging.

Their network of cGMP facilities operates with robust regulatory inspection track records across the FDA, EMA, Health Canada, and PMDA.